Bayer could have acquired all nine of the companies I own shares in for about $2B (assuming no premium). May speak more to the quality of the companies I invest in, LOL.
I propose that you name the nine companies and let readers decide :- )
I bet you don't own or own very few biotechs that generate sales already. It has been rather clear to me for quite some time that most acquirers have been focused on acquiring companies with approved products already.